You are here

  • Home
  • Archive
  • Volume 25, Issue 1
  • The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists

Article info

Article menu

Download PDFPDF

Review
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists

Authors

  • Piotr Merks Department of Pharmaceutical Technology, Faculty of Pharmacy, Ludwig Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Toruń, Poland PubMed articlesGoogle scholar articles
  • Damian Swieczkowski Department of Pharmaceutical Technology, Faculty of Pharmacy, Ludwig Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Toruń, Poland First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland PubMed articlesGoogle scholar articles
  • Michal Byliniak Regional Pharmaceutical Chamber, Warsaw, Poland PubMed articlesGoogle scholar articles
  • Mariola Drozd Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland PubMed articlesGoogle scholar articles
  • Katarzyna Krupa Tokarski-Olszewski Law Firm, Warsaw, Poland PubMed articlesGoogle scholar articles
  • Milosz Jaguszewski First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland PubMed articlesGoogle scholar articles
  • David A Brindley Said Business School, University of Oxford, Oxford, UK Department of Paediatrics, The University of Oxford, Oxford, UK The Oxford—UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK Centre for Behavioural Medicine, UCL School of Pharmacy, University College London, London, UK Harvard Stem Cell Institute, Cambridge, Massachusetts, USA USCF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI), USA PubMed articlesGoogle scholar articles
  • Bernard D Naughton Said Business School, University of Oxford, Oxford, UK Oxford University Hospitals NHS Trust, Oxford, UK Institute of Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Damian Świeczkowski, Department of Pharmaceutical Technology, Faculty of Pharmacy, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun with its registered office in Bydgoszcz, at Jagiellonska 13–15 Street, Bydgoszcz 85-067, Poland; d.swieczkowski{at}o2.pl
View Full Text

Citation

Merks P, Swieczkowski D, Byliniak M, et al
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists
European Journal of Hospital Pharmacy 2018;25:10-15.

Publication history

  • Received April 20, 2016
  • Revised May 30, 2016
  • Accepted July 5, 2016
  • First published July 27, 2016.
Online issue publication 
April 30, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/